Monday, May 23, 2022
HomeLatest NewsCovid-19FDA Alerts Providers to COVID-19 Rapid Test Recall

FDA Alerts Providers to COVID-19 Rapid Test Recall

The Food and Drug Administration announced a Class 1 recall of the E25Bio COVID-19 Direct Antigen Response Test. E25Bio is recalling its COVID-19 Direct Antigen Response Tests (DART) for several reasons, particularly that these tests were marketed and distributed to U.S. customers without authorization, clearance, or approval from the FDA. Labeling distributed with some of the tests also includes inaccurate claims and instructions, including a statement that misrepresents the test as FDA-authorized.

Due to the potential for false results, the FDA said health care providers who administered the test in the past two weeks and suspect an inaccurate result should consider retesting patients with an authorized test.

Click here for further details.

Stay Connected

Unified Voice Newsletter

Events This Month

may

24may12:00 pm1:00 pmFentanyl and the Evolution of the Opioid EpidemicAHA Webinar12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

24may12:00 pm1:00 pmThe ABCs of Grants Management Part 3SDAHO Webinar12:00 pm - 1:00 pm CST Event Type :Education Events,Webinar

24may3:00 pm4:00 pmPreparing Your Clinical Team for Hospital at HomeAHA Webinar3:00 pm - 4:00 pm CST Event Type :Education Events,Webinar

24mayAll Day25gpTRAC Telehealth Everywhere Conference(All Day) Event Type :Community Events

25may10:00 am11:00 amAssessing Your C.N.A Training ProgramSDAHO Webinar10:00 am - 11:00 am CST Event Type :Education Events,Webinar

X


By submitting this form, you are consenting to receive marketing emails from: SDAHO, 3708 W Brooks Place, Sioux Falls, SD, 57106, http://sdaho.org. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact